#United States #New York #Class Action #Gross Law Firm #Replimune Group

Replimune Group, Inc. Investors: Urgent Class Action Notice!

On September 11, 2025, the Gross Law Firm issued an important notice for shareholders of Replimune Group, Inc. (NASDAQ: REPL). If you bought shares during the defined class period — from November 22, 2024, to July 21, 2025 — this message is particularly relevant for you. The firm is urging affected shareholders to reach out for possible lead plaintiff appointments in this class action lawsuit, without any obligation to participate in such a role to secure recovery.

Background of the Class Action

During the class period, the lawsuit alleges that the defendants made materially false and misleading statements related to Replimune’s business and operations. Specifically, it points to significant issues with the IGNYTE trial's transparency and execution, which the FDA deemed inadequate and poorly controlled. Despite their knowledge of these shortcomings, the defendants purportedly overstated the trial’s potential, resulting in statements about Replimune’s business that were grossly misleading, lacking any reasonable basis.

Critical Dates

Shareholders should pay close attention to the upcoming deadlines. The last date to pursue lead plaintiff status in this case is September 22, 2025. If you purchased shares of REPL within the specified time frame, it is imperative that you register without delay to ensure your rights are protected.

Next Steps for Shareholders

By registering your share purchase with the Gross Law Firm, you will be included in ongoing portfolio monitoring, keeping you updated on the status and progression of the case. This proactive step ensures that you remain informed throughout the litigation, benefiting from potential recovery. Importantly, participation does not incur any costs, allowing you to be part of the action without financial risk.

Why Choose the Gross Law Firm?

The Gross Law Firm stands as a reputable force in the realm of class action lawsuits, well-known for advocating for investors who have faced losses due to deceitful and illegal corporate practices. Their primary goal is to ensure that companies maintain ethical business operations and uphold good corporate citizenship. This firm takes it upon itself to fight for the rights of investors who suffered from misleading information or lack of transparency that drove up a company’s stock artificially.

Contact Information

For further inquiries or to register your claim, please reach out to The Gross Law Firm:

• - Address: 15 West 38th Street, 12th floor, New York, NY 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

Do not overlook your opportunity to be involved in this significant case and protect your investment rights regarding Replimune Group, Inc. Ensure that you act promptly as the deadline approaches, because every investor deserves a fair chance at justice.